List of Tables
Table 1. Global Novel Cancer Diagnostic Solutions Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hardware
Table 3. Key Players of Software and Services
Table 4. Global Novel Cancer Diagnostic Solutions Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Novel Cancer Diagnostic Solutions Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Novel Cancer Diagnostic Solutions Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Novel Cancer Diagnostic Solutions Market Share by Region (2019-2024)
Table 8. Global Novel Cancer Diagnostic Solutions Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Novel Cancer Diagnostic Solutions Market Share by Region (2025-2030)
Table 10. Novel Cancer Diagnostic Solutions Market Trends
Table 11. Novel Cancer Diagnostic Solutions Market Drivers
Table 12. Novel Cancer Diagnostic Solutions Market Challenges
Table 13. Novel Cancer Diagnostic Solutions Market Restraints
Table 14. Global Novel Cancer Diagnostic Solutions Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Novel Cancer Diagnostic Solutions Market Share by Players (2019-2024)
Table 16. Global Top Novel Cancer Diagnostic Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Cancer Diagnostic Solutions as of 2023)
Table 17. Ranking of Global Top Novel Cancer Diagnostic Solutions Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Novel Cancer Diagnostic Solutions Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Novel Cancer Diagnostic Solutions Product Solution and Service
Table 21. Date of Enter into Novel Cancer Diagnostic Solutions Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Novel Cancer Diagnostic Solutions Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Novel Cancer Diagnostic Solutions Revenue Market Share by Type (2019-2024)
Table 25. Global Novel Cancer Diagnostic Solutions Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Novel Cancer Diagnostic Solutions Revenue Market Share by Type (2025-2030)
Table 27. Global Novel Cancer Diagnostic Solutions Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Novel Cancer Diagnostic Solutions Revenue Market Share by Application (2019-2024)
Table 29. Global Novel Cancer Diagnostic Solutions Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Novel Cancer Diagnostic Solutions Revenue Market Share by Application (2025-2030)
Table 31. North America Novel Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Novel Cancer Diagnostic Solutions Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Novel Cancer Diagnostic Solutions Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Novel Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Novel Cancer Diagnostic Solutions Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Novel Cancer Diagnostic Solutions Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Novel Cancer Diagnostic Solutions Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Novel Cancer Diagnostic Solutions Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Novel Cancer Diagnostic Solutions Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Novel Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Novel Cancer Diagnostic Solutions Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Novel Cancer Diagnostic Solutions Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Novel Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Novel Cancer Diagnostic Solutions Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Novel Cancer Diagnostic Solutions Market Size by Country (2025-2030) & (US$ Million)
Table 46. Philips Healthcare Company Detail
Table 47. Philips Healthcare Business Overview
Table 48. Philips Healthcare Novel Cancer Diagnostic Solutions Product
Table 49. Philips Healthcare Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 50. Philips Healthcare Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Novel Cancer Diagnostic Solutions Product
Table 54. Thermo Fisher Scientific Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Abbott Laboratories Company Detail
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Novel Cancer Diagnostic Solutions Product
Table 59. Abbott Laboratories Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 60. Abbott Laboratories Recent Development
Table 61. BD Company Detail
Table 62. BD Business Overview
Table 63. BD Novel Cancer Diagnostic Solutions Product
Table 64. BD Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 65. BD Recent Development
Table 66. Siemens Healthineers Company Detail
Table 67. Siemens Healthineers Business Overview
Table 68. Siemens Healthineers Novel Cancer Diagnostic Solutions Product
Table 69. Siemens Healthineers Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 70. Siemens Healthineers Recent Development
Table 71. PHC Holdings Company Detail
Table 72. PHC Holdings Business Overview
Table 73. PHC Holdings Novel Cancer Diagnostic Solutions Product
Table 74. PHC Holdings Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 75. PHC Holdings Recent Development
Table 76. Agilent Company Detail
Table 77. Agilent Business Overview
Table 78. Agilent Novel Cancer Diagnostic Solutions Product
Table 79. Agilent Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 80. Agilent Recent Development
Table 81. Sakura Finetek Company Detail
Table 82. Sakura Finetek Business Overview
Table 83. Sakura Finetek Novel Cancer Diagnostic Solutions Product
Table 84. Sakura Finetek Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 85. Sakura Finetek Recent Development
Table 86. Epredia Company Detail
Table 87. Epredia Business Overview
Table 88. Epredia Novel Cancer Diagnostic Solutions Product
Table 89. Epredia Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 90. Epredia Recent Development
Table 91. bioMeriux Company Detail
Table 92. bioMeriux Business Overview
Table 93. bioMeriux Novel Cancer Diagnostic Solutions Product
Table 94. bioMeriux Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 95. bioMeriux Recent Development
Table 96. MDx Health Company Detail
Table 97. MDx Health Business Overview
Table 98. MDx Health Novel Cancer Diagnostic Solutions Product
Table 99. MDx Health Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 100. MDx Health Recent Development
Table 101. DiaSorin Company Detail
Table 102. DiaSorin Business Overview
Table 103. DiaSorin Novel Cancer Diagnostic Solutions Product
Table 104. DiaSorin Revenue in Novel Cancer Diagnostic Solutions Business (2019-2024) & (US$ Million)
Table 105. DiaSorin Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Novel Cancer Diagnostic Solutions Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Novel Cancer Diagnostic Solutions Market Share by Type: 2023 VS 2030
Figure 3. Hardware Features
Figure 4. Software and Services Features
Figure 5. Global Novel Cancer Diagnostic Solutions Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Novel Cancer Diagnostic Solutions Market Share by Application: 2023 VS 2030
Figure 7. Hospital & Diagnostic Centers Case Studies
Figure 8. Laboratories & Research Institutes Case Studies
Figure 9. Novel Cancer Diagnostic Solutions Report Years Considered
Figure 10. Global Novel Cancer Diagnostic Solutions Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Novel Cancer Diagnostic Solutions Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Novel Cancer Diagnostic Solutions Market Share by Region: 2023 VS 2030
Figure 13. Global Novel Cancer Diagnostic Solutions Market Share by Players in 2023
Figure 14. Global Top Novel Cancer Diagnostic Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Cancer Diagnostic Solutions as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Novel Cancer Diagnostic Solutions Revenue in 2023
Figure 16. North America Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Novel Cancer Diagnostic Solutions Market Share by Country (2019-2030)
Figure 18. United States Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Novel Cancer Diagnostic Solutions Market Share by Country (2019-2030)
Figure 22. Germany Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Novel Cancer Diagnostic Solutions Market Share by Region (2019-2030)
Figure 30. China Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Novel Cancer Diagnostic Solutions Market Share by Country (2019-2030)
Figure 38. Mexico Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Novel Cancer Diagnostic Solutions Market Share by Country (2019-2030)
Figure 42. Turkey Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Novel Cancer Diagnostic Solutions Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Philips Healthcare Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 46. Abbott Laboratories Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 47. BD Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 48. Siemens Healthineers Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 49. PHC Holdings Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 50. Agilent Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 51. Sakura Finetek Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 52. Epredia Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 53. bioMeriux Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 54. MDx Health Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 55. DiaSorin Revenue Growth Rate in Novel Cancer Diagnostic Solutions Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed